Szisztémás szklerózis (szkleroderma): vizsgálatok itt: Kína
65 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleExploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
- Where
- Nanjing
- Életkor
- 18 év to 70 év
- People
- 72
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07558850 - No phaseNot yet taking people in KínaEfficacy and Safety of Firsekibart in the Treatment of Systemic Sclerosis
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 30
- Run by
- Tongji Hospital
See details and how to joinNCT07502105 - Korai 1. fázisTaking peopleA Study of CC312 for Relapsed/Refractory Autoimmune Diseases
- Where
- Deyang
- Életkor
- 18 év to 65 év
- People
- 6
- Run by
- CytoCares Inc
See details and how to joinNCT07193810 - Korai 1. fázisTaking peopleAllogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
- Where
- Hangzhou
- Életkor
- 3 év and over
- People
- 15
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07507201 - No phaseTaking peopleClinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 12
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07470151 - 1. fázisTaking peopleCT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
- Where
- Beijing
- Életkor
- 18 év to 60 év
- People
- 27
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06822881 - Korai 1. fázisTaking peopleClinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
- Where
- Bengbu
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- Nanjing Bioheng Biotech Co., Ltd.
See details and how to joinNCT06548607 - 1/2. fázisTaking peopleUmbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
- Where
- Beijing
- Életkor
- 6 év to 65 év
- People
- 45
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT06947473 - 1. fázisTaking peopleExploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
- Where
- Xuzhou
- Életkor
- 18 év to 65 év
- People
- 18
- Run by
- China Immunotech (Beijing) Biotechnology Co., Ltd.
See details and how to joinNCT07236801 - 1. fázisNot yet taking people in KínaYTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases
- Where
- Shanghai
- Életkor
- 5 év to 18 év
- People
- 12
- Run by
- Children's Hospital of Fudan University
See details and how to joinNCT07439029 - Korai 1. fázisTaking peopleExploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 60
- Run by
- Changhai Hospital
See details and how to joinNCT07246096 - 1. fázisTaking peopleCAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
- Where
- Hangzhou
- Életkor
- 3 év and over
- People
- 15
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07305116 - Korai 1. fázisTaking peopleClinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
- Where
- Lianyungang
- Életkor
- 18 év to 70 év
- People
- 18
- Run by
- Nanjing Bioheng Biotech Co., Ltd.
See details and how to joinNCT06775912 - No phaseTaking peopleSafety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis
- Where
- Guangzhou, Shanghai
- Életkor
- 18 év to 70 év
- People
- 48
- Run by
- Cytori Therapeutics
See details and how to joinNCT07360808 - Korai 1. fázisTaking peopleSafety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC
- Where
- Wuhan
- Életkor
- 18 év to 60 év
- People
- 12
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07355972 - 1. fázisTaking peopleCAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 12
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07315087 - No phaseTaking peopleAnti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
- Where
- Hangzhou
- Életkor
- 18 év to 65 év
- People
- 15
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06614270 - No phaseNot yet taking people in KínaA Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
- Where
- Tianjin
- Életkor
- 18 év to 65 év
- People
- 24
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07212322 - 1. fázisTaking peopleCAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 12
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06941129 - 1. fázisTaking peopleClinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
- Where
- Hangzhou
- Életkor
- 5 év and over
- People
- 11
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT07184450 - Korai 1. fázisTaking peopleSafety Study of CC312 in Autoimmune Disease Patients
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 18
- Run by
- CytoCares Inc
See details and how to joinNCT06888960 - 1. fázisTaking peopleA Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 44
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT07167537 - No phaseTaking peopleAnti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases
- Where
- Hefei
- Életkor
- 18 év and over
- People
- 18
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT07121777 - 1. fázisTaking peopleA Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 30
- Run by
- RenJi Hospital
See details and how to joinNCT06249438 - Korai 1. fázisTaking peopleThe Clinical Study on the Treatment of SSc With UTAA91 Injection.
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 24
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07000682